Journal List > Nat Prod Sci > v.23(1) > 1060660

Youn and Chang: Chemical Constituents of Fermented Noni (Morinda citrifolia) Juice Exudates and Their Biological Activity

Abstract

In a continuing study of the fermented noni (Morinda citrifolia) juice exudates, five compounds, heptanyl 2-O-β-D-xylofuranosyl-(1 → 6)-β-D-glucopyranoside (1), n-butyl β-D-glucopyranoside (2), (1S)-(3-ethenyl-phenyl)-1,2-ethanediol (3), (2S)-2-hydroxybutanedioic acid (4), and daucosterol (5) were isolated from the buthanol partition of the extract. The structures of the isolates were identified by 1D and 2D NMR, and MS experiments, as well as by comparison of their data with the published values. Among the isolates, compounds 1 – 3 were isolated for the first time from the plant species. The isolated compounds were evaluated for their cancer chemopreventive potential based on their ability to inhibit nitric oxide (NO) production and tumor necrosis factor alpha (TNF-α)-induced NF-κB activity, and quinonone reductase-1 (QR1)-inducing effect.

References

(1). Wang M.Y.., West B. J.., Jensen C. J.., Nowicki D.., Su C.., Palu A. K.., Anderson G.Acta Pharmacol. Sin. 2002. 23:1127–1141.
(2). Hirazumi A.., Furusawa E.., Chou S. C.., Hokama Y.Proc. West Pharmacol. Soc. 1996. 39:7–9.
(3). Palu A. K.., Kim A. H.., West B. J.., Deng S.., Jensen J.., White L. J.Ethnopharmacol. 2008. 115:502–506.
(4). Yang J.., Paulino R.., Janke-Stedronsky S.., Abawi F.Food Chem. 2007. 102:302–308.
(5). Jain R. K.., Srivastava S. D.Proc. Nat. Acad. Sci. India. 1992. 62A:11–13.
(6). Deng Y.., Chin Y. W.., Chai H.., Keller W. J.., Kinghorn A. D. J.Nat. Prod. 2007. 70:2049–2052.
(7). Srivastava M.., Singh J.Int. J. Pharmacog. 1993. 31:182–184.
(8). Liu G.., Bode A.., Ma W. Y.., Sang S.., Ho C. T.., Dong Z.Cancer Res. 2001. 61:5749–5756.
(9). Su B. N.., Pawlus A. D.., Jung H. A.., Keller W. J.., McLaughlin J. L.., Kinghorn A. D. J.Nat. Prod. 2005. 68:592–595.
(10). Kanchanapoom T.., Kasai R.., Yamasaki K.Phytochemistry. 2002. 59:551–556.
(11). Sang S.., Cheng X.., Zhu N.., Wang M.., Jhoo J. W.., Stark R. E.., Badmaev V.., Ghai G.., Rosen R. T.., Ho C.T. J.Nat. Prod. 2001. 64:799–800.
(12). Youn U. J.., Park E. J.., Kondratyuk T. P.., Sang-Ngern M.., Wall M. M.., Wei Y.., Pezzuto J. M.., Chang L. C. J.Nat. Prod. 2016. 79:1508–1513.
(13). Kondratyuk T. P.., Park E. J.., Yu R.., van Breemen R.B.., Asolkar R. N.., Murphy B. T.., Fenical W.., Pezzuto J. M.Mar. Drugs. 2012. 1:451–464.
(14). Park E.J.., Kondratyuk T.P.; Morrell, A.; Kiselev, E.; Conda-Sheridan, M.; Cushman, M.; Ahn, S.; Choi, Y.; White, J.J.; van Breemen, R.B.; Pezzuto, J.M. Cancer Prev. Res (Phila). 2011. 4:592–607.
(15). Song L. L.., Kosmeder II J. W.., Lee S. K.., Gerhäuser C.., Lantvit D.., Moon R. C.., Moriarty R. M.., Pezzuto J. M.Cancer Res. 1999. 59:578–585.
(16). Chiang Y.M.., Chuang D.Y.., Wang S.Y.., Kuo Y.H.., Tsai P.W.., Shyur L.F. J.Ethnopharmacol. 2004. 95:409–419.
(17). Yu H.L.., Xu J.H.., Lu W.Y.., Lin G.Q.Enzyme Microb. Tech. 2007. 40:354–361.
(18). Yang W.Q.., Qin X.D.., Shao H.J.., Fang L.Z.., Wang F.., Ding Z.H.., Dong Z.J.., Liu J.K. J.Basic Microbiol. 2007. 47:191–193.
(19). Boger D. L.., Panek J. S. J.Org. Chem. 1981. 46:1208–1210.
(20). Faizi S.., Ali M.., Saleem R.., Irfanullah ., Bibi S.Magn. Reson. Chem. 2001. 39:399–4. -21405.
crossref
(21). Choudhary A.., Kumar R.., Srivastava R. B.., Surapaneni S. K.., Tikoo K.., Singh I. P. J.Funct. Foods. 2015. 16:183–193.
(22). Watson C. Y.., Whish W. J. D.., Threadgill M. D.Bioorg. Med. Chem. 1998. 6:721–734.
(23). Akihisa T.., Tochizawa S.., Takahashi N.., Yamamoto A.., Zhang J.., Kikuchi T.., Fukatsu M.., Tokuda H.., Suzuki N.Chem. Biodivers. 2012. 9:1172–1187.

Fig. 1.
Structures of compounds 1 – 4 isolated from the fermented noni juice.
nps-23-16f1.tif
Fig. 2.
Important HMBC (arrow) and COSY (bold) correlations for 1 and 3.
nps-23-16f2.tif
Table 1.
Inhibition effects of compounds isolated from fermented noni juice on the TNF-α-induced NF-κB and NO production, and Quinone Reductacse-1 (QR-1) inducing activities
Compounds Nitrite assay NF-κB QR1
% inhib.a % surv.b IC50 (μM) % inhib.c % surv.d IC50 (μM) IR
1 5.3 ± 1.3 103.4 ± 2.8 nde 56.0 ± 2.1 87 ± 4.1 nd 0.8
2 13.3 ± 1.3 79.6 ± 2.8 nd 0 107.6 ± 2.8 nd 1.4
3 3.7 ± 0.1 104.2 ± 0.4 nd 28.0 ± 2.0 88.0 ± 4.0 nd 1.8
4 f
5 f
L-NMMAg     25.1 ± 2.3        
TPCKh           3.8 ± 0.6  
BAY-11h           2.0 ± 0.3  

a % inhibition of NO at a concentration of 50 μM,

b % survival at a concentration of 50 μM,

c % inhibition of NF-κB at 50 μM,

d % survival at concentration of 50 μM,

e nd, not determined,

f −, not tested,

g positive control for NO,

h positive control for NF-κB.

TOOLS
Similar articles